A mechanism-based model is able to simultaneously explain the effect of rhLCAT and HDL mimetics on biomarkers of reverse cholesterol transport

Therapeutic area :

Bosch R., K.Bergmann, Baverel P., Fairman D., Vis P. and Agoram B., A mechanism-based model is able to simultaneously explain the effect of rhLCAT and HDL mimetics on biomarkers of reverse cholesterol transport. PAGE.(2015) [Link to publication]